Alamar Biosciences NULISA Data Featured in More Than 140 Scientific Presentations at AAIC 2026, Highlighting Advances in Blood-Based Alzheimer’s Biomarker Profiling

The company will host a scientific workshop presenting emerging Alzheimer’s detection and staging research data for eMTBR-Tau and BD-pTau217. No trial outcomes, regulatory updates, or financial guidance are provided, so near-term market impact is likely limited.

Analysis

The company will host a scientific workshop presenting emerging Alzheimer’s detection and staging research data for eMTBR-Tau and BD-pTau217. No trial outcomes, regulatory updates, or financial guidance are provided, so near-term market impact is likely limited.